Page last updated: 2024-11-07

pilocarpine and Cytomegaloviral Retinitis

pilocarpine has been researched along with Cytomegaloviral Retinitis in 1 studies

Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Naguib, MJ1
Hassan, YR1
Abd-Elsalam, WH1

Other Studies

1 other study available for pilocarpine and Cytomegaloviral Retinitis

ArticleYear
3D printed ocusert laden with ultra-fluidic glycerosomes of ganciclovir for the management of ocular cytomegalovirus retinitis.
    International journal of pharmaceutics, 2021, Sep-25, Volume: 607

    Topics: Animals; Antiviral Agents; Cytomegalovirus Retinitis; Ganciclovir; Humans; Pilocarpine; Printing, Th

2021